These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10467528)

  • 1. [Modulation of angiogenesis. A new therapeutic tool for vascular diseases].
    Blot E; Delastre O; Lévesque H
    J Mal Vasc; 1999 Jun; 24(3):189-93. PubMed ID: 10467528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
    Griffioen AW; Molema G
    Pharmacol Rev; 2000 Jun; 52(2):237-68. PubMed ID: 10835101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and angiogenesis.
    Hoeben A; Landuyt B; Highley MS; Wildiers H; Van Oosterom AT; De Bruijn EA
    Pharmacol Rev; 2004 Dec; 56(4):549-80. PubMed ID: 15602010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation?
    Collinson DJ; Donnelly R
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):9-23. PubMed ID: 15177227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic and antiangiogenic gene therapy.
    Malecki M; Kolsut P; Proczka R
    Gene Ther; 2005 Oct; 12 Suppl 1():S159-69. PubMed ID: 16231050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.
    Agirbasli M
    Int J Clin Pract; 2005 Jan; 59(1):102-6. PubMed ID: 15707473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic angiogenesis as a new experimental treatment for vascular disease].
    Lucassen AM; de Waal RM; Verheugt FW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):650-5. PubMed ID: 10774292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial progenitor cells as a new agent contributing to vascular repair.
    Miller-Kasprzak E; Jagodziński PP
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis.
    Hadj-Slimane R; Lepelletier Y; Lopez N; Garbay C; Raynaud F
    Biochimie; 2007 Oct; 89(10):1234-44. PubMed ID: 17707573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.
    Slevin M; Krupinski J; Gaffney J; Matou S; West D; Delisser H; Savani RC; Kumar S
    Matrix Biol; 2007 Jan; 26(1):58-68. PubMed ID: 17055233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
    Ribatti D
    Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets.
    Alghisi GC; Rüegg C
    Endothelium; 2006; 13(2):113-35. PubMed ID: 16728329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulating angiogenesis in medicine.
    Carmeliet P
    J Intern Med; 2004 May; 255(5):538-61. PubMed ID: 15078497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Considerations on the therapeutic indications in chronic obliterating arterial diseases of lower limbs].
    De Maertelaere P
    Angeiologie; 1970; 22(3):179-90. PubMed ID: 5427841
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles and results of clinical therapeutic courses of chronic arterial obstruction diseases of lower extremities].
    Sohr C
    Dtsch Gesundheitsw; 1970 Oct; 25(42):1969-75. PubMed ID: 5517208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiogenesis and its clinical significance].
    Rodzaj M; Wilkołek P; Woźniak M; Gajos G
    Przegl Lek; 1996; 53(10):750-4. PubMed ID: 9091956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.